</s><s><s><s> bivalent and bivalent bivalent vaccine ( bivalent vs. bivalent ) is a novel, noninvasive, and safe vaccine for the prevention and treatment of cervical cancer. 
 the vaccine is approved by the us food and drug administration ( fda ) for use in the united states, europe, and other countries, and is currently under review for licensure by the u.s. and european governments. in 2014, 
, the fda granted an application for approval of the application for the approval of this application, which is being reviewed by the agency for the development of new and improved vaccines. </s>